Panacea Pharmaceuticals, Inc. – Trademark Portfolio

Entity Type: 03

Panacea Pharmaceuticals, Inc. holds 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 44 (Medical Services) — 9 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 4 Nice Classification classes. The owner is based in Potomac, MD.

9460 Tobin Circle

Potomac, MD 20854

16 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Panacea Pharmaceuticals, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

44
Medical Services (9 filings)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (6 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

1
Chemicals (1 filing)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

Frequently Asked Questions

How many trademarks does Panacea Pharmaceuticals, Inc. have?

Panacea Pharmaceuticals, Inc. has 16 U.S. trademarks filed with the USPTO.

What trademark classes does Panacea Pharmaceuticals, Inc. file in?

Panacea Pharmaceuticals, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 44 (Medical Services), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 1 (Chemicals). Class 44 covers medical services; veterinary services; hygienic and beauty care for human beings or animals.

What is Panacea Pharmaceuticals, Inc.'s trademark registration success rate?

Panacea Pharmaceuticals, Inc. has a 0% trademark registration rate, with 0 out of 16 resolved applications resulting in successful registration. Currently, 0 applications are pending review.